Format

Send to

Choose Destination
Mayo Clin Proc. 2004 Feb;79(2):211-9.

Contrast nephropathy after coronary angiography.

Author information

1
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Erratum in

  • Mayo Clin Proc. 2004 Mar;79(3):432. Dosage error in article text.

Abstract

Contrast nephropathy after coronary angiography is associated with considerable morbidity and mortality. We discuss the incidence, definition, and pathologic mechanisms of contrast nephropathy; provide an overview of risk factors; highlight proven preventive interventions; clarify which interventions have shown no benefit; and discuss future possibilities. The prevention of contrast nephropathy is crucial for the care of patients undergoing coronary angiography and should be possible with an understanding of risk factors and proven management strategies.

PMID:
14959916
DOI:
10.4065/79.2.211
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center